PALO ALTO, Calif., March 12 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTC:AVGO) (BULLETIN BOARD: AVGO) , a late stage biotechnology company...
PALO ALTO, Calif., Feb. 7 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTC:AVGO) (BULLETIN BOARD: AVGO) , a late-stage biotechnology company...
NEW YORK, Dec. 6 /PRNewswire-FirstCall/ -- Dr. Belinda Tsao-Nivaggioli, Chief Executive Officer of Avicena Group, Inc. (OTC:AVGO) (BULLETIN...
Selected Therapy Can Advance to Phase III Clinical Trial PALO ALTO, Calif., Dec. 3 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTC:AVGO...
PALO ALTO, Calif., Nov. 19 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTCBB: AVGO), a late-stage biotechnology company that develops central...
Patent Expands Existing IP to Treat ALS PALO ALTO, Calif., Nov. 13 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTC:AVGO) (BULLETIN BOARD:...
PALO ALTO, Calif., Nov. 1 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTC:AVGO) (BULLETIN BOARD: AVGO) , a late-stage biotechnology company...
PALO ALTO, Calif., Oct. 23 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTC:AVGO) (BULLETIN BOARD: AVGO) , a developer of novel pharmaceutical...
PALO ALTO, Calif., Oct. 18 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTC:AVGO) (BULLETIN BOARD: AVGO) , a late-stage biotechnology company...
PALO ALTO, Calif., Oct. 10 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTC:AVGO) (BULLETIN BOARD: AVGO) , a late-stage biotechnology company...
Expansion of Drug Pipeline and Advancement of Clinical Programs PALO ALTO, Calif., Oct. 8 /PRNewswire-FirstCall/ -- Avicena Group, Inc...
PALO ALTO, Calif., Sept. 28 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTC:AVGO) (BULLETIN BOARD: AVGO) , a late-stage biotechnology company...
Financing To Accelerate Trials and Commercialization PALO ALTO, Calif., Sept. 26 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTC:AVGO...
PALO ALTO, Calif., Aug. 31 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTC:AVGO) (BULLETIN BOARD: AVGO) , a late stage biotechnology company...
PALO ALTO, Calif., Aug. 28 /PRNewswire-FirstCall/ -- Avicena Group, Inc. (OTC:AVGO) (BULLETIN BOARD: AVGO) , a late-stage biotechnology company...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.